RecruitingNCT05534906

The Detection of Small Early Liver Cancer With Natural History Follow up


Sponsor

University of Oxford

Enrollment

250 participants

Start Date

May 23, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The SELINA study will recruit 200 patients with cirrhosis and small HCC and 50 patients with HCC but without cirrhosis (most of whom are expected to have FLD). Blood, urine and liver tissue samples (where available) will be collected for laboratory analysis. In a subgroup of patients (N=80, around 64 patients with HCC with liver cirrhosis and around 16 patients with HCC without liver cirrhosis), additional magnetic resonance liver imaging will be performed. The findings of the SELINA study aim to identify biomarkers that can be used to detect liver cancer at the earliest possible time, something we expect will increase the survival rate of HCC.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is looking for better ways to detect small, early-stage liver cancer (called hepatocellular carcinoma or HCC) and track how it naturally progresses over time. By following patients closely, researchers hope to improve early detection methods and treatment decisions. **You may be eligible if:** - You are 18 years or older - You have been diagnosed with small, early-stage liver cancer (1–3 tumors, each smaller than 3 cm) with preserved liver function - You have liver cirrhosis (scarring) from any cause, with or without liver cancer - Your diagnosis is recent (within the last 3 months) or you had a previous liver cancer that was fully treated more than 6 months ago and now have a new tumor in a different spot **You may NOT be eligible if:** - Your liver cancer is not confirmed or cannot be confirmed by biopsy (in cases without cirrhosis) - Your liver cancer has spread beyond the liver or is at an advanced stage - You are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood & Urine Samples

Blood and urine samples will be collected to help identify biomarkers that can be used to detect liver cancer at the earliest possible time

OTHERImaging

MRI \& MRE Scans


Locations(1)

Hepatology Clinical Trial Unit, John Radcliffe Hospital

Oxford, Oxfordshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05534906


Related Trials